NEW YORK – Arbor Biosciences announced on Wednesday an exclusive, global agreement with Biosearch Technologies to distribute Arbor's next-generation sequencing panels for ag-bio.
Under the terms of the partnership, Biosearch will provide Arbor's myBaits custom hybridization-based targeted NGS panels to commercial agricultural organizations and seed breeding companies. Arbor will continue to sell to academic and government research laboratories.
Biosearch is part of LGC Group, a UK-based company offering reference materials, reagents, and research services.
"The addition of custom hybridization-based targeted sequencing panels to our portfolio adds a critical component to our NGS offering for the ag-bio sector," Mark Dearden, VP of strategy and marketing at LGC, said in a statement.
Arbor, based in Ann Arbor, Michigan, was acquired by Chiral Technologies in January 2019. Over the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.